SGLT2 Inhibitors Fail to Impact MI Severity or Outcomes in T2DM Patients: Study
Germany: A retrospective cohort study has found that prior use of SGLT2 inhibitors in type 2 diabetes mellitus (T2DM) patients did not reduce myocardial infarction (MI) size or decrease adverse events during hospitalization for MI treated with percutaneous coronary intervention (PCI). The study, published in BMC Cardiovascular Disorders by Istvan Bojti and colleagues from the […]